school – Asia Tab

JCN Newswire

TANAKA Contributes to Venture Capital Fund “DMC No. 1 Investment Limited Partnership” Aiming to Establish a Medical Venture Ecosystem in Japan

20 12 月, 2022

TOKYO, Dec 20, 2022 - (JCN Newswire via SEAPRWire.com) - TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, announced today that it has made an equity contribution to the medical venture capital fund Diamond Medino Capital (DMC) No. 1 Investment Limited Partnership founded in Japan by Professor Terumitsu Hasebe (Professor, Faculty of Medicine, School of Medicine, Tokai University; Visiting Professor, Keio University School of Medicine; Visiting Professor, Massachusetts Institute of Technology/Harvard Medical School; medical doctor, PhD in Medicine, and PhD in Engineering). This is Japan's first medical venture capital fund established with an active medical professor serving as its representative. Through this equity contribution, TANAKA Kikinzoku Kogyo will contribute toward technological development in Japan's domestic medical and healthcare industry.Background and ObjectivesTANAKA Kikinzoku Kogyo decided to undertake this equity contribution as the company supports the fund's principle of establishing a medical venture ecosystem originating from Japan. TANAKA has previously worked with Professor Hasebe on national projects (under the Japan Agency for Medical Research and Development) for the joint development of advanced medical technologies, such as metal coils for embolization and long patency stent systems. The company is participating in this fund as the anchor limited partner to pursue the potential of precious metals - from a comprehensive perspective for the future of medicine and not just in terms of products and projects - and contribute to Japanese society.Currently in Japan, companies continue to face difficulties with rapid and sophisticated research and development due to issues such as fund procurement, a sense of urgency, and a shortage of human resources. In addition, there are cases where academic research groups with excellent technologies do not reach commercialization. Regarding these issues, this fund will support Japan's new and current medical ventures by closely assisting them in terms of human resources, capital, management, pharmaceutical, patent, exit, and other strategies. In this way, the fund will contribute to the well-being of patients by giving birth to venture companies with excellent academic technologies in the medical field, achieving early practical application of those technologies, and providing new medical equipment, pharmaceuticals, and medical-related services to medical frontlines. Furthermore, the fund seeks to realize a true ecosystem that uses the knowledge gained and human resources developed to take on challenges in new projects and research themes, as well as support future entrepreneurs.Additionally, the fund has the strength of being deeply involved in support of its investments from its unique position not found in other Japanese medical funds so far, such as its understanding of needs at the frontlines of medicine, knowledge regarding the latest technological trends, and the responses of Japan's and the United States' governments toward practical application.Through equity contribution to this fund, TANAKA Kikinzoku Kogyo also expects to strengthen relationships with Japan's medical ventures and expand future medical business, such as the development of new products and technologies, in the healthcare industry. The company will contribute to society by working on the social issue of establishing a medical venture ecosystem in Japan through this equity contribution.Professor Hasebe, the representative of Diamond Medino Capital Co., Ltd., which manages this fund, made the following comment regarding TANAKA Kikinzoku Kogyo's participation in the fund, "TANAKA Precious Metals is always seeking to contribute to the creation of a prosperous society as well as to the future of the planet through sustainable use of precious metals as a leading company in the field of precious metals. TANAKA deeply empathizes with our fund's principle of establishing a true ecosystem that helps achieve the early practical application of Japan's excellent core medical-related technologies and conveys them to the world, and I am very happy to be able to journey into the future together. In the past, I have built a profound relationship of cooperation with TANAKA in the application of high-value-added precious metals in medical devices, and I hope to demonstrate significant synergy through new challenges."About the Medical Venture EcosystemTraditionally, an ecosystem refers to a state in which living things survive through a cycle of interdependence. Modeled after such a system, in a medical venture ecosystem, companies and funds come together to support medical ventures with technological capabilities and future potential to build a sustainable cycle of new technology and product development in Japan while inheriting expertise gained through the development of new technologies. This fund is the first in Japan to be led by active parties in the field of medicine and aims to establish a medical venture ecosystem originating from Japan by supporting medical ventures.Profile of Professor Terumitsu HasebeTerumitsu Hasebe, medical doctor, PhD in Medicine (Keio University), and PhD in Engineering (Keio University)- Professor, Faculty of Medicine, School of Medicine, Tokai University; Visiting Professor, Keio University School of Medicine- Visiting Professor, Massachusetts Institute of Technology (MIT)/Harvard Medical School- AMED BRIDGE Project Leader (Seeds F)Professor Hasebe established the Hasebe Research Group, which combines medical science and engineering within Keio University's Faculty of Science and Technology. After obtaining his PhD in Engineering, while as a medical doctor, he undertook the development of medical devices with various global manufacturers. An example of one of his developments is the launch of the cerebral thrombosis stent retriever of Biomedical Solutions Inc. - Professor Hasebe was in charge of the entire preclinical study for the patent application in 2019 - that has become a premier device and continues to save many patients today. During the COVID-19 pandemic, to search for a new way to bring excellent academic technologies in Japan to the world, he launched this venture capital fund. He is an active medical doctor who has received more than 30 academic awards in Japan and overseas and is also a researcher and venture capitalist.Overview of DMC No. 1 Investment Limited Partnership- Fund name: DMC No. 1 Investment Limited Partnership- Established: November 2022This is a medical venture capital fund originating from Japan, with Professor Terumitsu Hasebe - an active medical professor with a PhD in Medicine as well as a PhD in Engineering - serving as its representative. The fund specializes in medical device and pharmaceutical development businesses, carrying out hands-on investments in venture companies from the seeding phase of research and development to the patent approval phase. It was launched to establish a medical venture ecosystem in Japan by providing research and development environments on par with those overseas and supporting Japan's medical ventures.About TANAKA Precious MetalsSince its foundation in 1885, TANAKA Precious Metals has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volumes of precious metals handled. Over the course of many years, TANAKA has not only manufactured and sold precious metal products for industry but also provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and around the world collaborate and cooperate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,225 employees, the Group's consolidated net sales for the fiscal year ending March 31, 2022, were 787.7 billion yen.**From the current consolidated fiscal year, the amounts of sales for some transactions are indicated as net values due to the application of the Accounting Standard for Revenue Recognition.Global industrial business websitehttps://tanaka-preciousmetals.com/en/Product inquiriesTANAKA Kikinzoku Kogyo K.K.https://tanaka-preciousmetals.com/en/inquiries-on-industrial-products/Press inquiriesTANAKA Holdings Co., Ltd.https://tanaka-preciousmetals.com/en/inquiries-for-media/This press release in PDF: https://www.acnnewswire.com/docs/files/20221220_EN.pdf Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)

JCN Newswire

Eisai and Washington University School of Medicine in St. Louis Enter Into Comprehensive Research Collaboration Agreement Aiming to Create New Therapies for Neurodegenerative Diseases

15 12 月, 2022

TOKYO, Dec 15, 2022 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. announced today that Eisai and Washington University School of Medicine in St. Louis have entered into a comprehensive research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD).Washington University is world leading in research on prevention, diagnosis, biomarkers and treatment of neurodegenerative diseases. The two organizations have been collaborating in AD research. The Phase II/III Tau NexGen Study conducted by the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by the University's School of Medicine, is exploring the safety, tolerability, biomarkers and cognitive efficacy of Eisai's anti-MTBR (microtubule binding region) tau antibody E2814 for the treatment of dominantly inherited Alzheimer's disease (DIAD). In this study, the anti-amyloid beta (Aβ) protofibril antibody lecanemab (generic name, development code: BAN2401) was selected as the background anti-amyloid agent.The collaboration strategically combines Washington University scientists" expertise in the fundamental and clinical research in neurodegenerative diseases, such as dementia, with Eisai's extensive experience in drug discovery and development. Using human biology, the aim is to create multiple novel therapeutic candidates as well as discover and identify biomarkers within the next five years. Eisai will have the option rights to develop and commercialize any compounds and biomarkers that meet certain criteria in terms of research and development milestones. In the case that Eisai chooses to exercise the options, Eisai will pay Washington University milestone payments and royalties on future sales of each licensed compounds.Dr. Teiji Kimura, Ph.D., Academia and Industry Alliance Officer, Deep Human Biology Learning (DHBL) Office of Eisai, commented, "Patients living with neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, struggle with critical unmet medical needs, which is the reason neurology is a key therapeutic area for Eisai. By collaborating with world-leading research institutions such as Washington University in St. Louis, Eisai is working to fulfill our human health care mission and provide potential new and targeted disease-modifying therapies with the ultimate goal of achieving a world free of neurodegenerative disease."About Washington University School of MedicineWashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 2,700 faculty. Its National Institutes of Health (NIH) research funding portfolio is the fourth largest among U.S. medical schools, has grown 54% in the last five years, and, together with institutional investment, WashU Medicine commits well over $1 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently within the top five in the country, with more than 1,790 faculty physicians practicing at over 60 locations and who are also the medical staffs of Barnes-Jewish and St. Louis Children's hospitals of BJC HealthCare. WashU Medicine has a storied history in MD/PhD training, recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120Eisai Inc (U.S.)Libby Holman　201-753-1945Libby_Holman@eisai.com Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

Thousands of educators, policymakers & technology leaders assemble to discuss the future of education in Thailand

25 8 月, 2022

BANGKOK, Aug 25, 2022 - (ACN Newswire via SEAPRWire.com) - On 14-15 September 2022, EDUtech Thailand (www.terrapinn.com/virtual/edutech-thailand/index.stm) will once again bring together the entire education ecosystem in Thailand to discuss new strategies, pedagogies, and innovations to bring inspiration in education to all. Over the two days, over 100 expert speakers (www.terrapinn.com/virtual/edutech-thailand/speakers.stm) from K-12 Schools and higher education institutions across Thailand will be addressing key themes such as Digital Leadership, Hybrid Learning, and Next-Gen Tools and Pedagogy in both English and Thai. Headlining the festival agenda is Chayaporn Wattanasiri, President of Mae Fah Lung University. She'll be sharing higher education's move into the digital age, especially in the area of assessments. Additional featured speakers at EDUtech Thailand include: - Prof Banchong Mahaisavariya, President, Mahidol University - Assoc. Prof Jirapon Sunkpho, Vice President of Information Technology, Graduate Program in IT Policy and Management, Thammasat University - Dr. Vinutthaput Phophet, Principal, Pakkred Secondary School - Asst. Prof. Anucha Somabut, Acting Director, Learning and Teaching Innovation Center, Khon Kaen University - Dr. Krittika Tanprasert, Director of the Learning Institute, King Mongkut's University of Technology Thonburi - Dr Atthawet Prougestaporn, Vice Rector for Academic and Faculty Affairs, Dusit Thani College - Dr. Lugkana Worasinchai, Co-Managing Director, IKI-SEA Vice President, Bangkok University - Varantorn (Ome) Thiensri, Associate Director of ICT, Harrow International AISL - Vinutthaput Phophet, Principal, Pakkred Secondary School - Dr Piyarat Khanthap, Director of ICT and K-12 ICT Coordinator, KIS International School, Bangkok - Arnan (Roger) Sipitakiat, Ph.D., Director, Teaching and Learning Innovation Center, Chiang Mai University - Dr Chanita Rukspollmuang, Assistant President, Siam University - Assoc. Prof. Chailerd Pichitpornchai, Director for Institute for Innovative Learning, Cognitive Neuroscience, Faculty of Medicine Siriraj Hospital, Mahidol University - Fuangarun Preededilok, Chair, Division of Development Education, Faculty of Education, Chulalongkorn University - Rebecca Owens, Head of Secondary, Bromsgrove International School - Wigran Jornthapa, School Director, Jornchanasuksa School - Jacqui Brelsford, University Counsellor, British International School, Phuket - Richard Burkhill, Director of Digital Learning, Rugby School, Thailand Running alongside the conference is a virtual exhibition hall showcasing the latest education technologies by edtech leaders including Lenovo, Google for Education, Amazon Web Services, Zoom, Coursera for Campus and more (www.terrapinn.com/virtual/edutech-thailand/partners.stm). The two-day free-to-attend conference and exhibition is expected to gather over 1,000 education stakeholders from Thailand and beyond. About EDUtech Thailand 2022 Date: 14-15 September 2022, LIVE ONLINE Conference & Exhibition opening hours: 08:30 am ICT Website: www.terrapinn.com/virtual/edutech-thailand/index.stm Register: https://secure.terrapinn.com/V5/step1.aspx?E=10577 About Terrapinn Terrapinn is a business media company. Its products are trade exhibitions, conferences, training solutions and electronic and print publications. For more information, please visit www.terrapinn.com. Note: Press registration for the conference is compulsory and advance scheduling for speaker/ sponsor interviews is recommended. Press passes are strictly reserved for reporters, journalists, editors only. Final issuance of press passes is subjected to Terrapinn's discretion. For your complimentary press pass, please contact the following: Edlyn Cho Marketing Terrapinn Pte Ltd edlyn.cho@terrapinn.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

ACN Newswire

Lifewire and The Harbour School Join Hands for the “e.a.r.t.h. Project”

15 6 月, 2022

HONG KONG, Jun 15, 2022 - (ACN Newswire via SEAPRWire.com) - Lifewire and The Harbour School join hands to honour Hong Kong's cultural history with the 'e.a.r.t.h. Project', breathing new life to the century-old Tai Tam Tuk Raw Water Pumping Station Staff Quarters Compound monuments. The site will be re-imagined as an early years campus for The Harbour School (THS), a K to Grade 12 international school well known for its world-class marine science program and inclusive ethos. Named the Earth Campus, it will provide approximately 150 places for children aged 3-8 (from PN - K3 initially). With its proximity to the Tai Tam Waterworks Heritage Trail featuring Hong Kong's rich waterworks, architectural and engineering history, the Earth Campus will also serve as an open space for education, leisure and cultural activities for the public, including guided tours, nature-related activities, wellbeing programmes, arts and music events. A Water Gallery displaying the history of the water supply in Hong Kong and the historical significance of the monuments, a new Annex with a viewing platform at the roof to allow the public to appreciate the front facade of the Pumping Station, the waterfront and nearby environment and social activity cum display areas will be set up for the public. As a highlight of Batch VI of Revitalisation Scheme from the HKSAR Government, the e.a.r.t.h. project is expected to be completed in 2028. The campus design will take into account the principle of "minimum intervention" and "reversibility" to preserve all characters defining elements of the monuments. Guided tours will be provided to educate the public about the architectural history of the Tai Tam Tuk area, as well as the revitalisation process of the monuments and their surrounding areas. Efforts will be made to collaborate with the community and like-minded NGOs to provide job opportunities for those in underprivileged families, including at-risk youths. Lifewire is a registered charitable institution with a vision to empower those in need in society and child patients with rare diseases and their families through supporting education and its future development. Its partner, THS, is an international school with forward-looking values and provides differentiated instruction for mainstream and neuro-diverse students. It is internationally recognised for its high-quality, award-winning experiential learning programs, and was named Best International School in Hong Kong Living's Education Awards 2021 for its outstanding social studies curriculum and technology program. At the International School Awards 2022, THS won for its marine science program and was also a Merit Winner in the Green Council's first Sustainable Development Goals (SDG) Achievement Awards. Ms. Rita Pang, Director of Lifewire Foundation Limited and Founder of See Change Education, said: "We feel very grateful to have this opportunity to reimagine the e.a.r.t.h. Project together with support from the government and the community including the Tai Tam Tuk Village Residents Fraternity Association, Tai Tam Tuk Dragon Boat Association, Scout Association of Hong Kong, etc. We are excited to work with education visionaries at the THS to set the platinum standard for inclusive schools in the future. Earth Campus will not only provide students with a unique environment for experiential learning that is rare in Hong Kong, but also serves as a scenic hub for the community to develop an appreciation for culture, history and heritage conservation."Dr. Jadis Blurton, Head of School of THS, said: "We are honoured and grateful to be working with Lifewire, the government and the community on this project of immense importance to Hong Kong's cultural history. The Earth Campus's waterside location provides an ideal setting for our award-winning marine science and social studies programs which are experiential, interdisciplinary, active and hands-on. THS welcomes diversity in our student body and has been delivering innovative approaches to learning since 2007 that benefit a wide range of learner abilities and put the joy back into learning and school. We are also excited by the opportunity to design activities to share with and educate interested members of the public about this site's fascinating architecture, ecology, and heritage."Ms. Carolyn Campbell, Parent of THS, said "The Harbour School's inclusive ethos and individualised education meant that all three of my children are able to go to the same school, including my child with additional learning needs who otherwise would not be able to access the local state curriculum. The Earth campus will enable access to high-quality education for all types of learners." 'e.a.r.t.h.' represents 'eco', 'art & culture', 'revitalisation', 'technology' and 'heritage', and it broadly captures the goals of the project to revitalise the Tai Tam Tuk Raw Water Pumping Station Staff Quarters Compound site using green construction with an emphasis on preserving heritage, conserving ecology, and promoting art, science and culture. The site includes extensive grounds which will provide nature-based and outdoor educational opportunities for its students. Alongside the school campus, we will establish a Water Gallery to promote the Tanka Boat Culture and the history of Hong Kong's waterworks. Bringing together the beauty of nature and education, our plan shall include guided eco-tours, mangrove planting, nature walks, wellness events, and other family-friendly leisure activities to encourage public participation and appreciation of the area and the Tai Tam Waterworks Heritage Trail. About LifewireLifewire (www.lifewire.hk) is a registered charitable institution founded in 2014. It is committed to bringing together corporates, chambers of commerce, organisations, and volunteer teams from all walks of life to help rare disease child patients and their families with medical and daily expenses, providing support and counseling, and spreading awareness about rare diseases to the society. Since its establishment, Lifewire has raised over HK$18 million for over 600 families. Its mission also encompasses life education, as Lifewire regularly visits campus to share the life stories of children who suffer from rare diseases, hoping to empower and encourage those children with rare diseases and inspire students to learn from them. About The Harbour SchoolThe Harbour School (THS) is a K to Grade 12 international school that aims to unlock the best in every student by taking a highly individual approach to teaching. The school was founded in 2007 and is already gaining a worldwide reputation as a center of excellence. It applies international best practices in adapting the US curriculum with an emphasis on 21st-century skills such as problem-solving, communication, teamwork, creativity and innovation. THS was named Best International School in Hong Kong Living's Education Awards 2021 where it also won awards for outstanding social studies curriculum and technology program. At the International School Awards 2022, THS won for its marine science program and was also a Merit Winner in the Green Council's first Sustainable Development Goals (SDG) Achievement Awards. For more information, please visit: www.ths.edu.hkMedia Inquiries:Yuki Lee (852) 3758 8355 yuki.lee@asiaalliedgroup.comSophie Po (852) 3758 8337 sophie.po@asiaalliedgroup.comNatalie Shiu (852) 3758 8366 natalie.shiu@asiaalliedgroup.comMaria Copp (852) 3905 0180 mariacopp@ths.edu.hkTo download all high-resolution images, please visit:https://www.dropbox.com/sh/wotmhbwi06s80oy/AABjE4mDJirLknt_Rrar_cCAa?dl=0 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)